4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-013364
Chief Development Officer sold 239 shares at $8.76 ($2,094)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Development Officer | 2023-05-18 | Sale | −239 | $8.76 | $2,094 | 90,447 | D |
| Open-market sales · 239 sh · avg $8.76 · $2,094 | |||||||
Loading xslF345X04/doc4.xml…